Background Data on the association of human immunodeficiency virus (HIV) infection with
adverse outcomes in patients with COVID-19 are conflicting. This systematic review and …

Abstract Background and Aims Older people have higher rates of comorbidities and may
experience more severe inflammatory responses; therefore, are at higher risk of death …

Background WHO has established a Global Clinical Platform for the clinical characterisation
of COVID-19 among hospitalised individuals. We assessed whether people living with HIV …

Background: Understanding the relationship between HIV and SARS-CoV-2 has important
public health implications. Objective: To summarize current research on COVID-19 among …

Aims GLP-1RA has many beneficial properties, including anti-inflammatory, anti-
obesogenic, pulmonary protective effects as well as beneficial impact on gut microbiome …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Vitamin D has many protective properties and potential role against acute lung injury. Low
serum vitamin D is associated with high risk of pneumonia and development of acute …

Background: The relationship between HIV (human immunodeficiency virus) and COVID-19
clinical outcome is uncertain, with conflicting data and hypotheses. We aimed to assess the …

Objective The present study aimed to perform a systematic review and meta-analysis on the
prevalence of one-year hospital readmissions and post-discharge all-cause mortality in …

Aim Delirium is a common presenting symptom among older patients. Patients who
presented with delirium may have a higher morbidity and mortality rate due to older age …